UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  February 5, 2020

 

Axcelis Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   000-30941   34-1818596
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

108 Cherry Hill Drive, Beverly, Massachusetts   01915
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code:  (978) 787-4000

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.001 per share ACLS NASDAQ Global Select Market

 

 

 

 

 

Item 2.02 Results of Operations and Financial Condition 

 

On February 5, 2020, Axcelis Technologies, Inc. (the “Company”) issued a press release regarding its financial results for the fourth quarter and year ended December 31, 2019. The Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.   Description
     
99.1   Press Release dated February 5, 2020. Filed herewith.

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: February 5, 2020 Axcelis Technologies, Inc.
   
  By: /s/ KEVIN J. BREWER
    Kevin J. Brewer
    Executive Vice President and Chief Financial Officer

 

3

 

Exhibit 99.1 

 

News Release

 

 

AXCELIS ANNOUNCES FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2019

 

Company Reports 94% Increase in Fourth Quarter System Revenues

 

BEVERLY, Mass. — Feb. 5, 2020—Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2019.

 

The Company reported fourth quarter revenue of $107.7 million, compared to $69.5 million for the third quarter of 2019. Operating profit for the quarter was $13.2 million, compared to $1.9 million for the third quarter. Net income for the quarter was $9.7 million, or $0.29 per diluted share, compared to net income for the third quarter of $0.7 million, or $0.02 per diluted share. Gross margin for the quarter was 41.1%, compared to 44% in the third quarter. Cash, cash equivalents and restricted cash were $146.5 million on December 31, 2019, compared to $162.2 million on September 30, 2019.

 

For the full year 2019, the Company reported revenue of $343.0 million, compared with $442.6 million for the full year 2018. Systems revenue for the year was $202.6 million, compared to $280.4 million in 2018. Operating profit was $24.2 million in 2019, compared to $60 million in 2018. Net income for the year was $17 million with diluted earnings per share of $0.50. This compares to 2018 net income of $45.9 million and earnings per diluted share of $1.35.

 

President and CEO Mary Puma commented, “In 2019 we continued to expand the Purion installed base, growing our large and diverse group of customers in key market segments. We extended our Purion product line with the launch of four new Purion implanters specifically targeted at these segments, while maintaining tight control of operating expenses. This allowed us to remain profitable through the cycle, deliver annual gross margins of 42.0%, sustain a healthy balance sheet, and institute a share repurchase program. Exiting the year with a 94% increase in system revenues in the fourth quarter demonstrates our strong competitive position as we enter what is expected to be an extended growth period driven by 5G.”

 

Business Outlook

 

For the first quarter ending March 31, 2020, Axcelis expects revenues of approximately $115 million. Gross margin in the first quarter is expected to be around 37%, impacted by the planned closure of three evaluation systems in the quarter. First quarter operating profit is forecasted to be approximately $9.5 million. Earnings per diluted share is expected to be approximately $0.21.

 

 

 

 

News Release  T:\tm206672-1\tm206672-1_8kseq1

 

Fourth Quarter and Full Year 2019 Conference Call

 

The Company will host a call to discuss the results for the fourth quarter and full year 2019 on Thursday, February 6, 2020 at 8:30 am ET. The call will be available to interested listeners via an audio webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by dialing 866.588.8911 (707.294.1561 outside North America). Participants calling into the conference call will be requested to provide the company name, Axcelis Technologies, and Conference ID: 3972885. Webcast replays will be available for 30 days following the call.

 

Safe Harbor Statement

 

This press release and the conference call contain forward-looking statements under the Private Securities Litigation Reform Act safe harbor provisions. These statements, which include our expectations for spending in our industry and guidance for future financial performance, are based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are outside the control of the Company, including that customer decisions to place orders or our product shipments may not occur when we expect, that orders may not be converted to revenue in any particular quarter, or at all, whether demand will continue for the semiconductor equipment we produce or, if not, whether we can successfully meet changing market requirements, and whether we will be able to maintain continuity of business relationships with and purchases by major customers. Increased competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and instability caused by changing global economic, political or financial conditions could also cause actual results to differ materially from those in our forward-looking statements. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

 

About Axcelis:

 

Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 40 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

 

Company Contacts

Investor Relations:

Doug Lawson
978.787.9552

 

Editorial/Media:

Maureen Hart
978.787.4266

 

 

 

 

News Release  T:\tm206672-1\tm206672-1_8kseq1

 

Axcelis Technologies, Inc.

Consolidated Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

 

   Three months ended   Twelve months ended 
   December 31,   December 31, 
   2019   2018   2019   2018 
Revenue:                    
Product  $102,304   $98,883   $319,505   $415,922 
Services   5,419    6,800    23,453    26,653 
Total revenue   107,723    105,683    342,958    442,575 
Cost of revenue:                    
Product   57,627    55,023    175,732    236,446 
Services   5,780    7,093    23,074    26,493 
Total cost of revenue   63,407    62,116    198,806    262,939 
Gross profit   44,316    43,567    144,152    179,636 
Operating expenses:                    
Research and development   13,596    14,245    53,931    51,876 
Sales and marketing   8,879    9,362    34,290    34,608 
General and administrative   8,629    8,438    31,726    33,193 
Total operating expenses   31,104    32,045    119,947    119,677 
Income from operations   13,212    11,522    24,205    59,959 
Other (expense) income:                    
Interest income   582    810    2,955    2,328 
Interest expense   (1,306)   (1,323)   (5,155)   (5,110)
Other, net   169    (762)   (1,083)   (2,472)
Total other expense   (555)   (1,275)   (3,283)   (5,254)
Income before income taxes   12,657    10,247    20,922    54,705 
Income tax provision   2,945    1,784    3,888    8,820 
Net income  $9,712   $8,463   $17,034   $45,885 
Net income per share:                    
Basic  $0.30   $0.26   $0.52   $1.42 
Diluted  $0.29   $0.25   $0.50   $1.35 
Shares used in computing net income per share:                    
Basic weighted average common shares   32,485    32,467    32,559    32,286 
Diluted weighted average common shares   33,848    33,886    33,828    34,002 

 

 

 

 

News Release T:\tm206672-1\tm206672-1_8kseq1 

 

Axcelis Technologies, Inc.

Consolidated Balance Sheets

(In thousands, except per share amounts)

(Unaudited)

 

   December 31,   December 31, 
   2019   2018 
ASSETS          
Current assets:          
Cash and cash equivalents  $139,881   $177,993 
Accounts receivable, net   83,753    78,727 
Inventories, net   140,364    129,000 
Prepaid expenses and other current assets   11,681    11,051 
Total current assets   375,679    396,771 
Property, plant and equipment, net   25,328    41,149 
Operating lease assets   5,849     
Finance lease assets, net   21,880     
Long-term restricted cash   6,653    6,909 
Deferred income taxes   68,060    71,939 
Other assets   44,645    31,673 
Total assets  $548,094   $548,441 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable  $25,341   $35,955 
Accrued compensation   7,631    19,218 
Warranty   2,759    4,819 
Income taxes   294    462 
Deferred revenue   24,601    19,513 
Current portion of long-term debt   399     
Other current liabilities   7,639    5,030 
Total current liabilities   68,664    84,997 
Finance lease obligation   48,149    47,757 
Long-term deferred revenue   4,650    3,071 
Other long-term liabilities   7,204    4,279 
            Total liabilities   128,667    140,104 
Commitments and contingencies          
Stockholders’ equity:          
Common stock, $0.001 par value, 75,000 shares authorized; 32,585 shares issued and outstanding at December 31, 2019; 32,558 shares issued and outstanding at December 31, 2018   33    33 
Additional paid-in capital   559,878    565,116 
Accumulated deficit   (140,226)   (157,260)
Accumulated other comprehensive (loss) income   (258)   448 
         Total stockholders’ equity   419,427    408,337 
Total liabilities and stockholders’ equity  $548,094   $548,441